Literature DB >> 13680532

Energy metabolism and cytotoxicity.

Didier Portilla1.   

Abstract

Fatty acids constitute a major source of metabolic fuel for energy production in kidney tissue. During acute renal failure (ARF) injury to the proximal tubule and medullary thick ascending limb leads to structural and functional alterations that result in reduced expression and activity of mitochondrial and peroxisomal fatty acid oxidation (FAO) enzymes. Reduced DNA binding activity of peroxisome proliferator activated receptor-alpha (PPARalpha) to its target genes and decreased expression of its tissue-specific coactivator PPAR-gamma-coactivator-1 (PGC-1) in the mouse proximal tubule and the medullary thick ascending limb, represent 2 potential mechanisms that account for the observed alterations of FAO during ARF. Pretreatment with PPARalpha ligands restores the expression and activity of renal FAO enzymes, and this metabolic alteration leads to amelioration of acute tubular necrosis caused by ischemia/reperfusion or cisplatin-induced ARF. More studies are needed to examine further the cellular mechanisms of substrate inhibition, and to determine if metabolic pathways, in addition to the recovery of FAO, account for the protective effect (s) of PPARalpha ligands during acute renal failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680532     DOI: 10.1016/s0270-9295(03)00088-3

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  24 in total

1.  The role of nuclear receptors in the kidney in obesity and metabolic syndrome.

Authors:  Claudia Tovar-Palacio; Nimbe Torres; Andrea Diaz-Villaseñor; Armando R Tovar
Journal:  Genes Nutr       Date:  2012-04-25       Impact factor: 5.523

2.  Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.

Authors:  Shenyang Li; Nithya Mariappan; Judit Megyesi; Brian Shank; Krishnaswamy Kannan; Sue Theus; Peter M Price; Jeremy S Duffield; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

3.  Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.

Authors:  Shenyang Li; Kiran Nagothu; Gouri Ranganathan; Syed M Ali; Brian Shank; Neriman Gokden; Srinivas Ayyadevara; Judit Megyesi; Gunilla Olivecrona; Sumant S Chugh; Sander Kersten; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

4.  Metabolomics for the early detection of cisplatin-induced nephrotoxicity.

Authors:  Takeshi Ezaki; Shin Nishiumi; Takeshi Azuma; Masaru Yoshida
Journal:  Toxicol Res (Camb)       Date:  2017-08-29       Impact factor: 3.524

5.  MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways.

Authors:  B Nelson Chau; Cuiyan Xin; Jochen Hartner; Shuyu Ren; Ana P Castano; Geoffrey Linn; Jian Li; Phong T Tran; Vivek Kaimal; Xinqiang Huang; Aaron N Chang; Shenyang Li; Aarti Kalra; Monica Grafals; Didier Portilla; Deidre A MacKenna; Stuart H Orkin; Jeremy S Duffield
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

6.  Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.

Authors:  Michael Kuncewitch; Weng Lang Yang; Asha Jacob; Adam Khader; Matthew Giangola; Jeff Nicastro; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2015-09-12       Impact factor: 3.982

7.  Role of PPARα and Its Agonist in Renal Diseases.

Authors:  Ching-Feng Cheng; Hsi-Hsien Chen; Heng Lin
Journal:  PPAR Res       Date:  2010-11-08       Impact factor: 4.964

8.  Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.

Authors:  Shenyang Li; Kiran K Nagothu; Varsha Desai; Taewon Lee; William Branham; Carrie Moland; Judit K Megyesi; Mark D Crew; Didier Portilla
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

Review 9.  Immune mechanisms and novel pharmacological therapies of acute kidney injury.

Authors:  Amandeep Bajwa; Gilbert R Kinsey; Mark D Okusa
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

10.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.